Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Income Statement [Abstract]
GRANT INCOME AND OTHER	$ 15,000	$ 5,024
OPERATING EXPENSES:
Research and development (excluding R&D depreciation of $109,545 and $114,612 respectively, included below)	2,924,722	2,456,185
Depreciation and amortization	133,450	138,425
General and administrative	2,001,285	1,853,690
Total operating expenses	5,059,457	4,448,300
OPERATING LOSS	(5,044,457)	(4,443,276)
GAIN ON DERIVATIVE INSTRUMENTS	2,746,198	956,470
INTEREST INCOME	29,415	29,055
INTEREST EXPENSE	(41,402)	(123,462)
NET LOSS	(2,310,246)	(3,581,213)
ISSUANCE OF ADDITIONAL SHARES DUE TO RESET PROVISIONS	0	(250,000)
MODIFICATION OF WARRANTS	0	(325,620)
NET LOSS AVAILABLE TO COMMON SHAREHOLDERS	$ (2,310,246)	$ (4,156,833)
NET LOSS PER COMMON SHARE-BASIC	$ (0.01)	$ (0.02)
NET LOSS PER COMMON SHARE-DILUTED	$ (0.02)	$ (0.02)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC	283,116,017	228,568,435
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED	283,116,017	228,568,435